Alsup Laurie Smaldone
Director, HUMANIGEN, INC.
Companies
- Arvinas (United States)Board member Nov 22, 2019 to now1
- Theravance Biopharma, Inc.Board member Feb 15, 2018 to now2
- BlackBerryBoard member Mar 2, 2020 to Jun 26, 20243
- Kinnate Biopharma Inc.Board member Dec 2, 2020 to Apr 5, 20244
- PARDES BIOSCIENCES, INC.Board member Sep 16, 2022 to Aug 31, 20235
- HUMANIGEN, INCBoard member Oct 23, 2013 to Jul 14, 20156
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Arvinas (United States) ARVN41,572 shares7$298.7K at $7.18Jun 24, 2026
- Theravance Biopharma, Inc. TBPH0 shares8Sep 23, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 23, 2026Returned to company 6,009 shares of Theravance Biopharma, Inc.8
- Sep 23, 2026Returned to company 74,980 shares of Theravance Biopharma, Inc.8
- Jun 24, 2026Granted 15,527 shares of Arvinas (United States)7
- Jun 12, 2026Granted 6,009 shares of Theravance Biopharma, Inc.9
- Jun 25, 2025Granted 16,025 shares of Arvinas (United States)10
- May 19, 2025Granted 10,649 shares of Theravance Biopharma, Inc.11
- May 29, 2024Granted 5,899 shares of Arvinas (United States)12
- May 8, 2024Granted 10,537 shares of Theravance Biopharma, Inc.13
- Jun 15, 2023Granted 4,121 shares of Arvinas (United States)14
- May 2, 2023Granted 9,132 shares of Theravance Biopharma, Inc.15
- Apr 26, 2022Granted 9,852 shares of Theravance Biopharma, Inc.16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARBlackBerry, Board member
- 4SEC EDGARKinnate Biopharma Inc., Board member
- 5
- 6SEC EDGARHUMANIGEN, INC, Board member
- 7
- 8
- 9SEC EDGARForm 4 filed Jun 16, 2026
- 10SEC EDGARForm 4 filed Jun 27, 2025
- 11SEC EDGARForm 4 filed May 21, 2025
- 12SEC EDGARForm 4 filed May 31, 2024
- 13SEC EDGARForm 4 filed May 10, 2024
- 14SEC EDGARForm 4 filed Jun 20, 2023
- 15SEC EDGARForm 4 filed May 4, 2023
- 16SEC EDGARForm 4 filed Apr 28, 2022